Hepatitis B reactivation after chemoimmunotherapy: screen before treatment

Lancet. 2021 Feb 6;397(10273):510. doi: 10.1016/S0140-6736(21)00210-5.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alanine Transaminase / blood
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antiviral Agents / administration & dosage
  • Guanine / administration & dosage
  • Guanine / analogs & derivatives
  • Hepatitis B / diagnosis*
  • Hepatitis B / drug therapy
  • Hepatitis B Surface Antigens / blood
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Recurrence
  • Rituximab / administration & dosage
  • Rituximab / adverse effects*
  • Virus Activation / drug effects*

Substances

  • Antiviral Agents
  • Hepatitis B Surface Antigens
  • Rituximab
  • entecavir
  • Guanine
  • Alanine Transaminase